Published on GHDx (https://ghdx.healthdata.org.)

Switzerland - Zurich SARS-CoV-2 Cohort: Long-term Long Covid Related Outcomes 2022

General Info

Geography 
Switzerland (CHE)
Zürich
Coverage type 
Subnational
Time period covered 
January, 2022 - December, 2022
Data type
Survey: Epi surveillance - Individual - Longitudinal
Keywords 
Anxiety, Body mass index, COVID-19, COVID-19 vaccines, Cognitive impairment, Cough, Disease outbreaks, EQ-5D, Education, Fatigue, Headache, Health status, Income, Long COVID, Loss of smell, Loss of taste, Mental health diagnostic interview, Pain, Sleep disorders, Symptoms, Tobacco smoking, Unipolar depressive disorders

Citation

Contributors 
Health Directorate Zurich (Switzerland)
Epidemiology, Biostatistics and Prevention Institute, University of Zurich
Funders 
University of Zurich Foundation
Health Directorate Zurich (Switzerland)
Federal Office of Public Health (Switzerland)
Horizon Europe, European Commission
Suggested citation 
Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Health Directorate Zurich (Switzerland). Switzerland - Zurich SARS-CoV-2 Cohort: Long-term Long Covid Related Outcomes 2022.
Source URL:https://ghdx.healthdata.org./record/switzerland-zurich-sars-cov-2-cohort-long-term-long-covid-related-outcomes-2022